Howard L. Kaufman, MD, FACS of Rutgers Cancer Institute of New Jersey discusses the treatment trends for 2017. He explains the significance of immunotherapy, but also the potential for intratumoral therapy with combination therapy in future treatments. This was recorded at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.
Treatment Trends 2017: Potential for Intratumoral Therapy
